A Study of OPC-41061 Orally Disintegrating (OD) Tablets Using 2 Different Formulations and 2 Dosing Regimens in Healthy Adult Male Subjects
Clinical trial NCT02994394 · COMPLETED
Trial details
- NCT number
- NCT02994394
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-06
- Primary completion
- 2017-02-28
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.